| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 钩藤碱 C; Pteropodine | CFN93247 | 5629-60-7 | C21H24N2O4 = 368.43 | 5mg | QQ客服：1457312923 |
| 盐酸吐根酚碱; Cephaeline Dihydrochloride | CFN93250 | 5853-29-2 | C28H40Cl2N2O4 = 539.53 | 5mg | QQ客服：2056216494 |
| 帽柱木碱; Mitraphylline | CFN91048 | 509-80-8 | C21H24N2O4 = 368.43 | 20mg | QQ客服：1413575084 |
| 轮环藤碱; Cycleanine | CFN93100 | 518-94-5 | C38H42N2O6 = 622.76 | 5mg | QQ客服：3257982914 |
| 2-Amino-N-(2-bromophenyl)benzamide | CFN94022 | 34489-85-5 | C13H11BrN2O = 291.14 | 5mg | QQ客服：2159513211 |
| 固蓝BB盐; 4-Benzamido-2,5-diethoxybenzenediazonium | CFN94033 | 5486-84-0 | C17H18N3O3+ = 312.34 | 5mg | QQ客服：215959384 |
| 8-羟基松脂醇二葡萄糖苷; 8-Hydroxypinoresinol diglucoside | CFN95083 | 112747-99-6 | C32H42O17 = 698.7 | 5mg | QQ客服：1413575084 |
| 3-甲基黄嘌呤; 3-Methylxanthine | CFN95087 | 1076-22-8 | C6H6N4O2 = 166.1 | 20mg | QQ客服：1457312923 |
| Bryonamide A; Bryonamide A | CFN91056 | 75268-14-3 | C9H11NO3 = 181.2 | 5mg | QQ客服：3257982914 |
| Bryonamide B; Bryonamide B | CFN91057 | 5942-25-6 | C10H13NO4 = 211.2 | 5mg | QQ客服：2159513211 |
| 盐酸辛可宁; Cinchonine hydrochloride | CFN93307 | 5949-11-1 | C19H23ClN2O = 330.85 | 20mg | QQ客服：215959384 |
| 吲哚-3-乙酸; Indole-3-acetic acid | CFN93308 | 87-51-4 | C10H9NO2 = 175.18 | 20mg | QQ客服：3257982914 |
| 玛咖酰胺 N-苄基十八碳酰胺; N-Benzyloctadecanamide | CFN93311 | 5327-45-7 | C25H43NO = 373.62 | 5mg | QQ客服：1457312923 |
| 去氢荷包牡丹碱; Dehydrodicentrine | CFN93312 | 19843-03-9 | C20H19NO4 = 337.37 | 5mg | QQ客服：2056216494 |
| 拓扑替康; Topotecan | CFN93314 | 123948-87-8 | C23H23N3O5 = 421.45 | 20mg | QQ客服：1413575084 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)